8-K: Crown Electrokinetics Secures $100 Million Stock Purchase Agreement with Liqueous, LP

Crown Electrokinetics Corp. has entered into a stock purchase agreement with Liqueous, LP, allowing the company to sell up to $100 million of its common stock over a 24-month period.

Summary

• Crown Electrokinetics Corp. has entered into a Common Stock Purchase Agreement with Liqueous, LP, which allows Crown to sell up to $100 million of newly issued shares of its common stock.
• The agreement gives Crown the right, but not the obligation, to sell shares to Liqueous, while Liqueous is obligated to purchase them.
• Crown will control the timing and amount of any sales over a 24-month period after a registration statement is declared effective by the SEC.
• The purchase price will be 97% of the lowest daily VWAP during the two business days prior to the sale notice.
• Liqueous cannot own more than 4.99% of Crown's outstanding common stock, unless the company obtains stockholder approval.
• Crown also entered into a Registration Rights Agreement, agreeing to file a registration statement for the resale of these shares within 30 days.
• The company must use commercially reasonable efforts to have the registration statement declared effective within 90 days, or 45 days if the SEC indicates no review.

Sentiment

Score: 7

Explanation: The agreement provides a significant source of potential funding, which is positive. However, the potential for dilution and the discount to VWAP temper the overall sentiment.

Positives

• The agreement provides Crown Electrokinetics with access to a significant amount of capital, up to $100 million.
• Crown has control over the timing and amount of share sales, allowing flexibility in managing its funding needs.
• The agreement does not require Crown to issue any shares as a commitment fee, reducing immediate costs.
• The company has already received shareholder approval to issue shares in excess of the Exchange Cap at its Annual Meeting of Stockholders held on June 14, 2024.

Negatives

• The purchase price is set at a discount of 3% to the lowest daily VWAP, which could dilute existing shareholders.
• The agreement could lead to significant dilution of existing shareholders if the full $100 million is utilized.
• The company is obligated to file a registration statement within 30 days, which could be costly and time-consuming.
• The company is subject to Nasdaq rules that limit the number of shares that can be issued without shareholder approval.

Risks

• The actual sales of shares will depend on market conditions and the trading price of the common stock, which are subject to change.
• The company's ability to access the full $100 million is not guaranteed and depends on its own decisions and market factors.
• There is a risk that the registration statement may not be declared effective by the SEC within the desired timeframe.
• The agreement could lead to significant dilution of existing shareholders if the full $100 million is utilized.

Future Outlook

The company has the potential to raise up to $100 million over the next 24 months, which will be used to fund operations. The actual amount raised will depend on market conditions and the company's decisions.

Management Comments

• The document does not contain any direct quotes from management.

Industry Context

This type of agreement is common for companies seeking to raise capital, particularly those in growth phases. It provides a flexible way to access funding as needed, rather than through a traditional equity offering.

Comparison to Industry Standards

• The agreement is structured similarly to other at-the-market (ATM) offerings, which are common in the industry.
• The 3% discount to VWAP is a typical feature of these types of agreements, reflecting the risk taken by the investor.
• The 4.99% ownership cap is also a standard provision to prevent a single investor from gaining too much control without shareholder approval.
• The 24-month term is a common timeframe for such agreements, allowing the company to access capital over a reasonable period.

Stakeholder Impact

• Shareholders may experience dilution if the full $100 million is utilized.
• The company will have access to additional capital, which could support growth and operations.
• The agreement could impact the share price, depending on market reaction and the pace of share sales.

Next Steps

• Crown Electrokinetics must file a registration statement for the resale of the shares within 30 days.
• The company must use commercially reasonable efforts to have the registration statement declared effective by the SEC.
• Crown will then have the option to sell shares to Liqueous over the next 24 months.

Key Dates

Keywords

stock purchase agreement, common stock, Liqueous LP, capital raise, share dilution, registration statement, VWAP, funding, equity financing